Background: Hepatitis B virus is a partially double-stranded circular DNA virus and is a member of the Hepadnaviridae family. The virus consists of a core capsid which contains viral DNA and this is surrounded by an envelope containing surface antigen (HBsAg). Both whole, incomplete virus particles, consisting entirely of HBsAg, are produced during replication of HBV. The HBsAg particles vary greatly in morphology and are found in high concentrations in early acute infection and continue to be produced in chronic disease.
Introduction
HBsAg ELISA is used for the qualitative determination of hepatitis B surface antigen (HBsAg) in human serum or plasma. This test is indicated for the screening of blood and blood products to be used for transfusion and an aid for the diagnosis of existing or previous hepatitis B infection. Hepatitis B surface antigen (HBsAg) and Hepatitis C (HCV) antibodies, similar to that which has existed for HIV since 1988. 1 Hepatitis B surface antigen (HBsAg) appears 1-7 weeks before biochemical evidence of liver disease or jaundice. Three weeks after the onset of acute hepatitis almost half of the volunteers will still be positive for HBsAg. In the chronic carrier state, the HBsAg persists for long periods, even for life with no seroconversion to the corresponding antibodies. Abha et. al., [2] studied that the incidence of HBsAg positivity among high risk hospital personnel. Tribal population of Udaipur District in Southern Rajasthan, the prevalence of HBsAg observed by Jain [3] . The various international researcher Mahoney and Stewart [4] progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. The detailed study on hepatitis B virus studied by Hollinger. [5] After initial HBV infection, a proportion of patients fail to clear infectious material from the blood stream and become chronic carriers. Shi et. al [6] studied that the hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission. Hamida et al. [7] observed the maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya. Therefore, screening for HBsAg is highly desirable for all donors, pregnant women and people in highrisk groups. 
Materials and Methods

Specimen
A 5-ml venous blood sample was collected in a pilot tube from all volunteers, for the testing of HBsAg. The blood was allowed to clot at room temperature and the serum was separated after centrifugation at a low speed. The serum sample was then subjected to requested tests. 
HBsAg Testing Kit
Results
The results of a study in Solapur, Maharashtra State, India, among 767 volunteers (male 470 and female 297), aged 05-55 years, who required medical check-ups. Blood samples, collected during March to May 2010, were tested for HBsAg using a third-generation ELISA kit. Of the 767 volunteers, male 14(1.82%) and female 09(1.17%) were positive for HBsAg. Lack of awareness and carrier state seems to be the reason for this increased prevalence among the volunteers. Table-1 shown that the sex specific HBsAg positivity prevalence percentage and Table-2 shown that the Chi-square tests for independence of sex and positivity of HBsAg: observed frequencies and Table 3 shows the expected frequencies. The results shows on Table 2 and Table 3 
Discussion
Sohrabi [8] observed seroepidemiologic study of hepatitis B and measuring contamination in laboratory personnel in Tehran. In Nepal Shrestha [9] observed the seroepidemiology of hepatitis B. Hovig et. al., [10] studied that the antibody to hepatitis-B surface antigen among employees in the National Hospital, Oslo, Norway. In Northern India, Tripathi et.al., [11] find the low prevalence of Hepatitis B Virus and Hepatitis C Virus co-infection in patients with Human Immunodeficiency Virus. Batham et. al. [12] systematically reviewed the metaanalysis of prevalence of hepatitis B in India. Kotwal and Kelkar [13] observed the hepatitis-B antigen in endemic hepatitis at Aurangabad. Hepatitis B positivity among medical personnel studied by Gupta et al. [14] and hepatitis-B virus infection in hospital personnel pointed out by Elavia and banker. [15] The prevalence of chronic HBsAg carriers in India, it was 5% and in Sri Lanka, it was 1% for the year 2000. [16] [17] Singh et al. [18] studied the screening for hepatitis B and C viral markers among nursing students in a tertiary care hospital in India. Transfusion-transmitted infection of hepatitis B virus observed by Niederhauser et al. [19] Five-year studied in India by Meena et. al. [20] observed that the prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital. The results compared to the above studies, moreover, in Solapur, Maharashtra State, India, a study showed that the prevalence rate of HBsAg positive volunteers was 2.99% and positivity was significantly more among the males.
Considering the findings of HBsAg positive volunteers in our study and similar studies both at home and abroad, we would like to emphasize that the overall prevalence percentage of the HBsAg infection is less as compared to the past finding.. The present result shows that the prevalence percentage is decreased due to awareness of education and vaccination.
